Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Pantazi, E., Valenza, G., Hess, M. et al. The atopic dermatitis market. Nat Rev Drug Discov 17, 237–238 (2018). https://doi.org/10.1038/nrd.2017.192
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.192
- Springer Nature Limited
This article is cited by
-
Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers
Natural Products and Bioprospecting (2023)
-
Carboranes in drug discovery, chemical biology and molecular imaging
Nature Reviews Chemistry (2022)
-
Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
Stem Cell Research & Therapy (2021)
-
Atopic dermatitis
Nature Reviews Disease Primers (2018)